JW Therapeutics
Shanghai, CN · 2 known investors
A biopharmaceutical company developing CAR-T cell therapies for cancer treatment. The company produces Benastim (瑞基奥仑赛注射液), a CAR-T therapeutic approved by China's National Medical Products Administration.
BiotechHealthtechMedical Devices
Investors · 2
In the news
- JW Therapeutics Shareholders Back All AGM Resolutions, Approve Fresh Capital Mandates - TipRanks.comtipranks.com · 2026
- JW Therapeutics Grants to Employees Raise Red Flag as Insiders Stay Silent on Share Buyingainvest.com · 2026
- JW Therapeutics - Medtech Alertmedtechalert.com · 2022
- JW Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- JW Therapeutics, a China CAR-T biotech formed by Juno and WuXi, gains $90M series A | Fierce Biotechfiercebiotech.com · 2018
- JW Therapeutics Raises $90M in Series A Financing - FinSMEsfinsmes.com · 2018